Skup podataka
Skup podataka: covid-19_results_mar_dec_2020.zip, 1.22 GB
Pravo pristupa: Otvoren pristup

Dokumentacija: efficacy_of_fda_approved_hiv_drugs_on_sars-cov-2.txt, 720 bytes
Pravo pristupa: Otvoren pristup
Opis datoteke:
Methodology description (engleski)

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Citirajte ovaj rad

Tomić, D. (2021). Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein [Skup podataka]. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, Draško. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković, 2021. 26.10.2021. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, Draško. 2021. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, D. 2021. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković. [Online]. [Citirano 26.10.2021.]. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić D. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. [Internet]. Institut Ruđer Bošković: , HR; 2021, [pristupljeno 26.10.2021.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:241:733364.

D. Tomić, Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein, Institut Ruđer Bošković, 2021. Citirano: 26.10.2021. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:241:733364.